TLR4 and neoplasm: Wei et al. reported that G. lucidum polysaccharides (EORP, 50–200 μg/mL) upregulated the expressions of two surface receptors on macrophages (toll-like receptor 4 (TLR4) and CD14), thus improving their ability to recognize and respond to LPS to kill tumor cells [85].